MCK · News · 20260805N
Operating Income and Margins
MCKESSON CORP · 2026-08-05 · Importance 47 · Surprise 48
Fiscal Q1 2027 gross profit was reported at approximately $3.7 billion. Adjusted EPS rose 20% year over year to $9.93, while some coverage reported lower net income and diluted EPS on a GAAP basis despite higher sales. Specialty pharmaceuticals and oncology services supported margin strength, but the U.S. Pharmaceutical operating margin contracted according to third-party reporting. Pricing pressure, specialty-pharmaceutical mix and higher capital expenditures were cited as factors limiting margin expansion.